Gynecologic Oncology at ASCO 2021: Endometrial Cancer

Managing Ovarian Cancer Recurrence (2021)Подробнее

Society of Gynecological Oncology; A holiday message from our CEOПодробнее

Gynecologic Oncology at ESMO Congress 2021: Phase 2 study in patients with R/M Cervical cancerПодробнее

Importance of understanding molecular subtypes in endometrial cancerПодробнее

Managing Side Effects from Surgery, Chemotherapy and Immunotherapy for Uterine CancerПодробнее

ONCOLOGY FORUM 2021 HALL AПодробнее

Women’s Reproductive Cancers: An overview of cervical, ovarian and uterine cancersПодробнее

Gynecological cancers: co-morbidities and best supportive careПодробнее

Gynecologic Oncology at ESMO Congress 2021: Trial Study in Cervical CancerПодробнее

Women with Synchronous Uterine and Ovarian Cancers: Misdiagnosed and Mistreated?Подробнее

ICG in Gynecology and Gynecological OncologyПодробнее

Endometrial Cancer New Developments in Management, Future of Women's Health,& Recurrent MiscarriagesПодробнее

Report Back from SGO: What’s the Latest in Uterine Cancer?Подробнее

Rebastinib plus paclitaxel shows encouraging anti-tumor activity in endometrial cancerПодробнее

Ovarian cancer subtypes reframed as distinct oncogenic journeys: A post-genomic approach to researchПодробнее

Gynecologic Oncology at ASCO 2021: Upfront Therapy in Ovarian CancerПодробнее

What is Gynecologic Oncology?Подробнее

Endometrial Cancer:2021Подробнее

2021 ASCO Annual Meeting Highlights by ELO. Gynecologic Cancer II. Neuroendocrine Tumors.Channel 1.Подробнее